ATAI
ATAI
NASDAQ · Pharmaceuticals

Ataibeckley Inc

$4.03
+0.02 (+0.50%)
As of May 10, 10:08 PM ET ·
Analyst Consensus
Strong Buy
20
Analysts
High
Coverage
Buy 19 95%
Hold 1 5%
Sell 0 0%
Price Target
Analyst Price Target +903.5% upside
Low Target $27.58
Average Target $40.44
High Target $50.46
Current Price $4.03
Current
$4.03
Target
$40.44
$27.58 $40.44 avg $50.46
Scenario Analysis
Bear Case
$27.58
584.4%
Low target
Base Case
$40.44
+903.5%
Avg target
Bull Case
$50.46
+1,152.1%
High target
Risk/Reward
2.0x
Balanced
Price in Context
52-Week High
$6.75
-40.3% from high
52-Week Low
$1.29
+212.4% from low
Target vs 52W High
$40.44
+499.1% vs high
Next Earnings Report
May 11, 2026
Today
EPS Est: $-0.10
Earnings in today. Analyst targets may shift significantly after the report.
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
RDY
Dr. Reddy's Laboratories
Hold 45 51% +0.0%
LLY
Eli Lilly and Co.
Strong Buy 39 77% $1,330.33 +40.3%
JNJ
Johnson & Johnson
Buy 32 63% $299.55 +35.3%
MRK
Merck & Co. Inc.
Buy 35 71% $159.27 +43.0%
PFE
Pfizer Inc.
Hold 36 44% $33.90 +32.0%
BMY
Bristol-Myers Squibb Co
Hold 36 42% $174.50 +210.7%
ZTS
Zoetis Inc
Buy 25 60% $209.87 +153.4%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -28.6%